Fri.Nov 26, 2021

article thumbnail

SBS News Australia: Australian company wrongly named by Taliban over Afghanistan cannabis deal

Cannabis Law Report

Although we do feel sorry for the company in question we have to say that this does ring of Schadenfreude all round considering the revelations over the past 16 months about the way the Australian military acted in Afghanistan. And let’s be honest. if an Australian cannabis company was offered loads of dosh by the Taliban to produce and process their cannabis and they thought they could get away with it ,it’d be a done deal.

article thumbnail

‘Pot shop’ panic plagues the Canadian cannabis industry

Leafly

As the number of cannabis retail locations skyrocket, so does moral panic about a new kind of 'herb'n sprawl'. The post ‘Pot shop’ panic plagues the Canadian cannabis industry appeared first on Leafly.

Retail 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Does Marijuana Work?

Leafwell

The science behind medical cannabis is complicated. Why? The cannabis plant contains up to 150 cannabinoids, 220 terpenes/terpenoids and 20 flavonoids, all of which have different effects when used on their own or combined with each other. This makes cannabis a very versatile medication, but also difficult to figure out. However, we do know that cannabis is a “pharmacy in a plant” meaning that it.

article thumbnail

Cannabis in Ancient Literature

Cannabis Life Network

Cannabis is an ancient herb that is well known for its recreational properties. Apart from such use, the herb was also well-known to ancient healers for its medicinal properties. The mention of Cannabis in ancient texts tells a lot about the location’s culture and society. Almost all cultures of antiquity have notable comments about Cannabis. […].

article thumbnail

Where the Money Grows: Learning the Industry Trends in Medical Cannabis, Recreational Marijuana, Hemp, and Beyond

Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken

The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.

article thumbnail

Complete Guide to the Endocannabinoid System

Leafwell

Every person – and many animals – has their own endocannabinoid system (ECS), a complex network of receptors, lipids, and enzymes that plays a large role in governing homeostasis and how we individually experience cannabis. While the ECS was identified only in the late 1980s, it quickly became one of the most important scientific discoveries to date.

Sleep 81

More Trending

article thumbnail

Flora Growth Forms JV With Avaria Health and Beauty to Distribute Award-Winning Pain Products Across LATAM

Cannabis Law Report

Flora Growth and Avaria Health and Beauty form a joint venture for the sale of its award-winning KaLaya brand across Latin America (“LATAM”), increasing the value of Flora Labs’ 2,500+ Colombian distribution channels. Flora Lab, Flora Growth’s wholly-owned GMP-certified manufacturing facility, will be responsible for producing the cannabinoid-infused products for the JV, with an emphasis on incorporating cannabidiol (“CBD”) into its product formulations.

article thumbnail

Weekly Cannabis Roundup November 26

Veriheal

Illinois cops can no longer search vehicles that smell of raw cannabis, Ohioans have gathered almost enough signatures on their proposal to legalize recreational cannabis in the state, and Connecticut police have called on lawmakers to protect the public from laced cannabis by accelerating the opening of state dispensaries. Let’s dive into this week’s cannanews.

article thumbnail

Answer of the Day for Nov 27, 2021

TheAnswerPage

Are most oncologists in the US prepared to discuss the use of medical cannabis with their patients? According to a national survey of 400 medical oncologists, 70% felt unprepared to discuss cannabis use and to make clinical recommendations for their patients. “M. Weiss, S. Danese, K.Aliano Ruiz, S. Kjelstrom, M. Buckley, A. Leitenberger, M. Bollmann-Jenkins, S.

article thumbnail

Global Legal Cannabis Market (2021 to 2025) – Featuring Aurora Cannabis, Bhang and Jazz Pharmaceuticals Among Others – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Global Legal Cannabis Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The publisher has been monitoring the legal cannabis market and it is poised to grow by $34.91 bn during 2021-2025, progressing at a CAGR of over 21% during the forecast period. The report on the legal cannabis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis c

article thumbnail

Despite Initial Setback, Florida Lawmakers Remain Intent on Psychedelics Reform

Canna Law Blog

In April of this year, Florida’s first attempt at psychedelics reform failed, as a House subcommittee rejected HB 549. This bill, introduced by Rep. Michael Grieco (D-Miami Beach), would have legalized the use of psilocybin for mental treatment in the nation’s third most populous state. Despite this setback, 2021 could yet be a pivotal year for psychedelics in Florida.

article thumbnail

DCM Announces Webcast Information for DCM | Investor Day to be Held on December 1, 2021

Cannabis Law Report

BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. (TSX: DCM) (“DCM” or the “Company”), a leading provider of marketing and business communication solutions to companies across North America, is pleased to announce details for its first ever DCM | Investor Day, beginning at 3:00 p.m. EST on Wednesday, December 1, 2021.

Data 52
article thumbnail

Did Taliban sign a $450 million Cannabis deal with Australian firm?

Cannabis Law Report

article thumbnail

Boll & Branch Black Friday & Cyber Monday Deals (2021): Best Beddings Sales Compared by Deal Tomato

Cannabis Law Report

Black Friday 2021 deals experts summarize all the top Boll & Branch deals for Black Friday & Cyber Monday 2021, including deals on bedding sets & duvet sets. BOSTON–(BUSINESS WIRE)–Find all the top Boll & Branch deals for Black Friday & Cyber Monday, together with all the latest bed sheets, sheet sets, bedding inserts & more deals.

article thumbnail

Best Boll & Branch Black Friday & Cyber Monday Deals 2021: Bed Sheets & Sheet Set Savings Reviewed by Retail Fuse

Cannabis Law Report

The top Black Friday & Cyber Monday Boll & Branch deals for 2021, featuring all the latest quilt sets & embroidered design deals. BOSTON–(BUSINESS WIRE)–Here’s a comparison of all the top Boll & Branch deals for Black Friday & Cyber Monday 2021, including savings on bath towels & bundles. Links to the best deals are listed below.

Retail 52
article thumbnail

Can CBD Improve Cognitive Function?

Cannabis Law Report

CBD shows potential for improving cognitive function, according to a new study that tested the impact of CBD on mice with traumatic brain injury. The study found that CBD helped with lowering the impact of brain injury while also supporting faster recovery of cognitive skills. Traumatic brain injury (TBI) is a condition that results from severe head trauma.

CBD 52
article thumbnail

Can-Fite Reports Third Quarter 2021 Financial Results & Provides Clinical Update

Cannabis Law Report

PETACH TIKVA, Israel–(BUSINESS WIRE)– Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended September 30, 2021. Corporate and Clinical Development Highlights Include: Completed Patient Enrollment in Phase III Psoriasis Study – The Phase III Comfort™ study completed patient enrollment